April 30, 2020

Cordis Names Roberto Patarca, MD, as Chief Medical Officer

April 30, 2020—Cordis, a Cardinal Health company, announced the appointment of Roberto Patarca, MD, PhD, as Chief Medical Officer, effective April 13, 2020. Dr. Patarca will lead Cordis Clinical, Medical, Clinical Education, and Training and customer Key Opinion Leader engagement functions.

According to Cordis, Dr. Patarca has 15 years of industry experience in global medical affairs and clinical research. His primary focus has been in clinical studies, education, product safety, quality assurance, fieldwork, and strategic planning. He has been a clinician and clinical trialist, basic scientist and bio analyst (molecular to cellular diagnostics), and an editor of biomedical journals.

“Dr. Patarca brings a great blend of strategic clarity and deep relationships with cardiovascular key opinion leaders,” commented Cordis President Patrick Holt in the company’s press release. “He is an experienced global leader and brings an entrepreneurial, hands-on spirit that will help us continue to build our 60-year heritage by focusing on quality, innovation, and education.”

Also in the Cordis announcement, Dr. Patarca stated, “I am excited to join Cordis, a company of many firsts in interventional devices, and to foster its impact as a trusted and valued partner of health care professionals and systems, professional societies, regulatory bodies, and academia to advance cardiovascular medicine for the benefit of patients worldwide.”

The company noted that Dr. Patarca’s previous experience includes positions as Medical Strategy Lead and Medical Affairs Director, Antibacterials and Antifungals for Hospital Systems at Merck & Co. Inc. Additionally, he has served as a member of advisory committees to two Secretaries of the United States Department of Health and Human Services and worked in academia at University of Miami School of Medicine/Jackson Memorial Hospital in Miami, Florida, and Harvard Medical School in Cambridge, Massachusetts.

His therapeutic experience includes interventional cardiology, electrophysiology, immunology, infectious diseases, and oncology. As a result, he has long-standing scientific and educational partnerships globally with cardiovascular opinion leaders.

Dr. Patarca received a Master of Science in Biology from Central University of Venezuela, a PhD in Experimental Pathology from Harvard University, and an MD from University of Miami School of Medicine.


May 2, 2020

Venus Medtech Partners With Opus Medical Therapies to Develop Transcatheter Valve Technology for the Greater China Market

April 30, 2020

CMS Issues Second Round of Waivers and Rule Changes During COVID-19 Pandemic